McCrimmon RJ, Cheng AYY, Galstyan G, Djaballah K, et al. iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study. Diabetes Obes Metab 2022 Aug 19. doi: 10.1111/dom.14844.
PMID: 36123617